WallStSmart

Medtronic PLC (MDT)vsTexas Instruments Incorporated (TXN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Medtronic PLC generates 101% more annual revenue ($35.48B vs $17.68B). TXN leads profitability with a 28.3% profit margin vs 13.0%. TXN appears more attractively valued with a PEG of 1.47. TXN earns a higher WallStSmart Score of 63/100 (C+).

MDT

Buy

56

out of 100

Grade: C

Growth: 4.0Profit: 6.5Value: 7.3Quality: 5.0

TXN

Buy

63

out of 100

Grade: C+

Growth: 3.3Profit: 9.5Value: 7.3Quality: 7.8
Piotroski: 5/9Altman Z: 4.12
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MDTSignificantly Overvalued (-255.7%)

Margin of Safety

-255.7%

Fair Value

$24.34

Current Price

$87.89

$63.55 premium

UndervaluedFair: $24.34Overvalued
TXNSignificantly Overvalued (-430.9%)

Margin of Safety

-430.9%

Fair Value

$37.06

Current Price

$196.77

$159.71 premium

UndervaluedFair: $37.06Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDT4 strengths · Avg: 8.3/10
Market CapQuality
$110.62B9/10

Large-cap with strong market position

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.0%8/10

Strong operational efficiency at 20.0%

Free Cash FlowQuality
$2.30B8/10

Generating 2.3B in free cash flow

TXN6 strengths · Avg: 9.3/10
Return on EquityProfitability
30.1%10/10

Every $100 of equity generates 30 in profit

Operating MarginProfitability
34.0%10/10

Strong operational efficiency at 34.0%

Altman Z-ScoreHealth
4.1210/10

Safe zone — low bankruptcy risk

Market CapQuality
$179.15B9/10

Large-cap with strong market position

Profit MarginProfitability
28.3%9/10

Keeps 28 of every $100 in revenue as profit

Free Cash FlowQuality
$1.33B8/10

Generating 1.3B in free cash flow

Areas to Watch

MDT1 concerns · Avg: 2.0/10
EPS GrowthGrowth
-11.8%2/10

Earnings declined 11.8%

TXN3 concerns · Avg: 3.3/10
P/E RatioValuation
36.1x4/10

Premium valuation, high expectations priced in

Price/BookValuation
11.0x4/10

Trading at 11.0x book value

EPS GrowthGrowth
-3.2%2/10

Earnings declined 3.2%

Comparative Analysis Report

WallStSmart Research

Bull Case : MDT

The strongest argument for MDT centers on Market Cap, Price/Book, Operating Margin.

Bull Case : TXN

The strongest argument for TXN centers on Return on Equity, Operating Margin, Altman Z-Score. Profitability is solid with margins at 28.3% and operating margin at 34.0%. Revenue growth of 10.4% demonstrates continued momentum.

Bear Case : MDT

The primary concerns for MDT are EPS Growth.

Bear Case : TXN

The primary concerns for TXN are P/E Ratio, Price/Book, EPS Growth.

Key Dynamics to Monitor

MDT profiles as a value stock while TXN is a mature play — different risk/reward profiles.

TXN carries more volatility with a beta of 0.98 — expect wider price swings.

TXN is growing revenue faster at 10.4% — sustainability is the question.

MDT generates stronger free cash flow (2.3B), providing more financial flexibility.

Bottom Line

TXN scores higher overall (63/100 vs 56/100), backed by strong 28.3% margins and 10.4% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medtronic PLC

HEALTHCARE · MEDICAL DEVICES · USA

Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.

Texas Instruments Incorporated

TECHNOLOGY · SEMICONDUCTORS · USA

Texas Instruments Incorporated (TI) is an American technology company headquartered in Dallas, Texas, that designs and manufactures semiconductors and various integrated circuits, which it sells to electronics designers and manufacturers globally. It is one of the top 10 semiconductor companies worldwide based on sales volume.

Want to dig deeper into these stocks?